DOCT.L vs. GNOM.L
DOCT.L (L&G Healthcare Breakthrough UCITS ETF) and GNOM.L (Global X Genomics & Biotechnology UCITS ETF) are both Health & Biotech Equities funds - DOCT.L tracks the MSCI World/Health Care NR USD while GNOM.L tracks the Global X Genomics & Biotechnology UCITS ETF. Both are passively managed. Over the past 3 years, DOCT.L returned 8.21%/yr vs 4.58%/yr for GNOM.L. Their correlation of 0.85 suggests significant overlap in exposure. DOCT.L charges 0.49%/yr vs 0.50%/yr for GNOM.L.
Performance
DOCT.L vs. GNOM.L - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, DOCT.L achieves a 6.89% return, which is significantly lower than GNOM.L's 22.10% return.
DOCT.L
- 1D
- 1.46%
- 1M
- 8.05%
- 6M
- 2.37%
- YTD
- 6.89%
- 1Y
- 36.46%
- 3Y*
- 8.21%
- 5Y*
- -3.16%
- 10Y*
- —
GNOM.L
- 1D
- -0.17%
- 1M
- 11.69%
- 6M
- 15.71%
- YTD
- 22.10%
- 1Y
- 62.79%
- 3Y*
- 4.58%
- 5Y*
- —
- 10Y*
- —
DOCT.L vs. GNOM.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
DOCT.L L&G Healthcare Breakthrough UCITS ETF | 6.89% | 24.90% | 1.96% | -1.16% | -33.86% | -7.19% |
GNOM.L Global X Genomics & Biotechnology UCITS ETF | 22.10% | 19.30% | -17.99% | -5.77% | -37.21% | -8.59% |
Correlation
The correlation between DOCT.L and GNOM.L is 0.80, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.80 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.82 |
Correlation (All Time) Calculated using the full available price history since Nov 2, 2021 | 0.85 |
The correlation between DOCT.L and GNOM.L has been stable across timeframes, ranging from 0.80 to 0.85 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
DOCT.L vs. GNOM.L — Risk / Return Rank
DOCT.L
GNOM.L
DOCT.L vs. GNOM.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for L&G Healthcare Breakthrough UCITS ETF (DOCT.L) and Global X Genomics & Biotechnology UCITS ETF (GNOM.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| DOCT.L | GNOM.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.43 | ||
| Sortino ratioReturn per unit of downside risk | -0.45 | ||
| Omega ratioGain probability vs. loss probability | 1.29 | 1.34 | -0.05 |
| Calmar ratioReturn relative to maximum drawdown | 2.13 | 3.35 | -1.21 |
| Martin ratioReturn relative to average drawdown | 5.00 | 9.16 | -4.16 |
Loading charts...
Drawdowns
DOCT.L vs. GNOM.L - Drawdown Comparison
The maximum DOCT.L drawdown since its inception was -57.54%, smaller than the maximum GNOM.L drawdown of -69.32%. Use the drawdown chart below to compare losses from any high point for DOCT.L and GNOM.L.
Loading charts...
Drawdown Indicators
| DOCT.L | GNOM.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -57.54% | -69.32% | +11.78% |
Max Drawdown (1Y)Largest decline over 1 year | -17.02% | -18.91% | +1.89% |
Max Drawdown (3Y)Largest decline over 3 years | -28.75% | -44.77% | +16.02% |
Max Drawdown (5Y)Largest decline over 5 years | -55.80% | — | — |
Current DrawdownCurrent decline from peak | -25.19% | -37.11% | +11.92% |
Average DrawdownAverage peak-to-trough decline | -28.91% | -47.16% | +18.25% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.27% | 6.92% | +0.35% |
Volatility
DOCT.L vs. GNOM.L - Volatility Comparison
The current volatility for L&G Healthcare Breakthrough UCITS ETF (DOCT.L) is 6.81%, while Global X Genomics & Biotechnology UCITS ETF (GNOM.L) has a volatility of 8.41%. This indicates that DOCT.L experiences smaller price fluctuations and is considered to be less risky than GNOM.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| DOCT.L | GNOM.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.81% | 8.41% | -1.60% |
Volatility (6M)Calculated over the trailing 6-month period | 16.61% | 22.18% | -5.57% |
Volatility (1Y)Calculated over the trailing 1-year period | 21.54% | 29.87% | -8.33% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 24.12% | 33.11% | -8.99% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 24.67% | 33.11% | -8.44% |
DOCT.L vs. GNOM.L - Expense Ratio Comparison
DOCT.L has a 0.49% expense ratio, which is lower than GNOM.L's 0.50% expense ratio.
Dividends
DOCT.L vs. GNOM.L - Dividend Comparison
Neither DOCT.L nor GNOM.L has paid dividends to shareholders.
Frequently Asked Questions
DOCT.L and GNOM.L have a correlation of 0.80, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, DOCT.L is cheaper at 0.49% per year. The better choice depends on whether you care most about return, fees, risk, or income.
DOCT.L is cheaper with a 0.49% expense ratio, compared with 0.50% for GNOM.L.
DOCT.L tracks MSCI World/Health Care NR USD, while GNOM.L tracks Global X Genomics & Biotechnology UCITS ETF. They also come from different issuers: Legal & General and Global X. Their fees differ too: 0.49% for DOCT.L and 0.50% for GNOM.L.
Find the right allocation for DOCT.L and GNOM.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer